American Association of Poison Control Centers: K2 herbal marijuana substitute spurred poison calls

Doctors and clinicians at U.S. poison centers say that a synthetic version of marijuana that is frequently sold as incense has spurred symptoms including a fast heart rate, confusion and nausea.

K2, an herbal marijuana substitute also known as "spice," is a blend of herbs sprayed with a synthetic marijuana-like drug, and has spurred at least 112 calls to U.S. poison centers since 2009, including 59 calls since March 1, 2010.

Poison centers in Arkansas, Colorado, Delaware, Georgia, Idaho, Indiana, Iowa, Kentucky, Louisiana, Maryland, Missouri, North Carolina, Texas, Virginia and Wyoming have been among those reporting calls regarding synthetic marijuana.

Among the states that have seen the highest number of calls: Missouri, which Missouri Poison Center Medical Director Anthony Scalzo says has received approximately 40 calls about the substance since last November.

In response to the calls, the state of Missouri issued a health alert about the products, and the St. Charles County Council recently passed an emergency ordinance banning the sale of such products, which are sold in gas stations, convenience stores and "head shops."

Scalzo said the reactions being reported – including agitation, anxiety, an extremely fast, racing heartbeat and elevated blood pressure – are the opposite of what would be expected from marijuana, which is a source of concern.

"This is not what we'd expect from these compounds," he said.

The product is marketed as incense or potpourri and has been sold since 2006 for about $30 to $40 per three-gram bag. Scalzo said parents should be on the lookout for what looks like incense in their child's room and watch to see if their children seem more anxious than usual.

No deaths have been reported, but symptoms have also included agitation, dizziness, nausea, vomiting, tremors and chest pain in some cases.

Earlier this month, Kansas became the first state to ban the substance when Gov. Mark Parkinson signed a bill outlawing the substance on March 10. States including Missouri, Nebraska and Georgia are also considering measures that would ban the sale of such products.

Jim Hirt, executive director of the American Association of Poison Control Centers, urged those with questions about K2 to call their local poison center.

"Poison centers are available 24 hours a day, seven days a week, to answer questions about K2 or any other substance that could be harmful to your health," he said. "These poison centers are staffed with medical professionals who are trained to know the impact of a substance and how to treat a poison exposure."

The American Association of Poison Control Centers supports the nation's poison control centers. Poison centers offer free and confidential services 24 hours a day, seven days a week. For questions about poison or poison prevention, call your local poison control center at 1 (800) 222-1222.

www.aapcc.org

Comments

  1. Aubree Aubree United States says:

    Meanwhile, pharmaceutical companies are running ads all day long on television for their drugs. The listing of the possible side effects of these drugs takes up over half of the freaking commercial. While I think a ban is ridiculous and highly hypocritical, I do think people need to wise up.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer patients